Current advance in treatment of infective keratitis by UVA-Riboflavin cross-linking
Corneal collagen cross-linking(CXL)is the latest corneal shape technology applied in clinic. CXL can increase corneal rigidity after collagen cross-linking used ultraviolet A. CXL also can increase the mechanical and biochemical stability of the stroma tissue and prevent the progression of corneal e...
Main Authors: | Zhao-Qin Hao, Jie Wu, Jin-Xin Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2013-06-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://www.ies.net.cn/gjykcn/ch/reader/view_abstract.aspx?file_no=201306019&flag=1 |
Similar Items
-
Current advance in treatment of fungal keratitis by corneal collagen cross-linking
by: Qi Li, et al.
Published: (2017-07-01) -
PACK-CXL: Corneal cross-linking for treatment of infectious keratitis
by: David Tabibian, et al.
Published: (2015-01-01) -
Riboflavin/UV-A corneal phototherapy as stand-alone management of ulcerative keratitis in dogs
by: A Marchegiani, et al.
Published: (2022-04-01) -
Corneal Collagen Crosslinking Treatment in a Case with Pneumococcal Keratitis
by: Ayşe Bozkurt Oflaz, et al.
Published: (2017-06-01) -
Ultraviolet-A Light and Riboflavin Therapy for Acanthamoeba Keratitis: A Case Report
by: Leopoldo Garduño-Vieyra, et al.
Published: (2011-08-01)